Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M6LN
|
|||
| Former ID |
DIB009069
|
|||
| Drug Name |
L-ornithine L-aspartate
|
|||
| Synonyms |
Hepenax; LOLA; Hepa-Merz
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Hepatic encephalopathy [ICD-11: DB99.5] | Approved | [1], [2] | |
| Company |
Merz & Co GmbH
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H19N3O6
|
|||
| Canonical SMILES |
C(CC(C(=O)O)N)CN.C(C(C(=O)O)N)C(=O)O
|
|||
| InChI |
1S/C5H12N2O2.C4H7NO4/c6-3-1-2-4(7)5(8)9;5-2(4(8)9)1-3(6)7/h4H,1-3,6-7H2,(H,8,9);2H,1,5H2,(H,6,7)(H,8,9)/t4-;2-/m00/s1
|
|||
| InChIKey |
IXUZXIMQZIMPSQ-ZBRNBAAYSA-N
|
|||
| CAS Number |
CAS 3230-94-2
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT01847651) Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.